The Foundation staff discussed the drug development process, ongoing clinical trials for inherited retinal diseases and dry AMD, and the importance of transparency and safety in clinical research. They also highlighted the experiences of individuals who have participated in clinical trials, emphasizing the potential benefits and challenges of these trials. The conversation ended with a Q&A session and a discussion on personal experiences with eye diseases and treatments.
- Catégories
- Webinar
Commentaires